The school year is in full swing for Big Pharma as the drug giants continue to pump resources into their collaborations with academia. While the pair have always worked together, those partnerships have taken on new forms in recent years. As the new models enter their senior year, it’s easy to see which companies are making the grade.
The old model of pharma-academia partnerships was characterized by negotiations with tech transfer offices, with pharma in-licensing potential products from...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?